Disposable Endoscope - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The disposable endoscopes market size in 2026 is estimated at USD 3.73 billion, growing from 2025 value of USD 3.47 billion with 2031 projections showing USD 5.37 billion, growing at 7.54% CAGR over 2026-2031. This report is Segmented by Product (Gastroscopes, Bronchoscopes, Duodenoscopes, and More), Application Type (Gastroenterology, Pulmonology, Urology, and More), Procedure Type (Diagnostic and Therapeutic), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Disposable Endoscope Market Trends and Insights

Technological Break-Even of Single-Use CMOS Imaging Sensors

Low-cost CMOS modules now deliver diagnostic-grade resolution at a production cost 35.0% lower than in 2022, enabling community hospitals to replace reusable towers with plug-and-play disposables. Firmware upgrades performed at the factory eliminate console downtime and push procurement teams to evaluate scopes on annual pixel gains, a shift mirroring consumer-electronics replacement cycles. As a result, the disposable endoscopes market is widening beyond tertiary centers, with rural facilities adopting single-use models that remove reprocessing bottlenecks and avoid capital outlays on washers.

Implementation of Accelerated Hospital Accreditation Standards

Revised Joint Commission rules introduced in 2024 mandate real-time tracking of every high-level disinfection cycle, forcing mid-size endoscopy suites to invest over USD 50,000 in compliance hardware. The capital strain has shortened the payback period on single-use scopes to as little as 12 months in high-volume centers, convincing finance committees that disposables solve both infection-control gaps and escalating labor costs. By redeploying sterile-processing staff to patient-facing roles, hospitals align spending with value-based-care objectives and boost clinical availability.

Uncertain Cost-Benefit Equation for Low-Volume Community Hospitals

Facilities performing under 500 procedures per year face 20% higher per-case costs when moving to disposables because their existing reprocessing rooms stand under-utilized. Many adopt hybrid fleets, reserving disposables for high-risk ERCP or ICU bronchoscopy while retaining reusable colonoscopes for routine screenings. The dual-inventory model complicates waste audits and purchasing but allows administrators to reconcile infection-control imperatives with budget realities.

Other drivers and restraints analyzed in the detailed report include:

• Increased Demand for Bronchoscopy in ICU Settings Post-COVID
• Reimbursement Code Expansion for Category III Single-Use Endoscopes
• Restricted Lumen Size Limits Advanced Therapeutic Interventions

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Bronchoscopes generated 31.62% of the disposable endoscopes market share in 2025, underpinning the segment’s leadership with their slim profiles that navigate distal bronchi without compromising image fidelity. Teaching hospitals favor single-use bronchoscopes as training devices because scheduling conflicts linked to shared equipment vanish, improving educational throughput. Elevated ventilator-associated pneumonia surveillance sustains procedural volume, and combined with predictable per-case costs, cements the disposable endoscopes market size for bronchoscopes on a solid growth path. Suppliers respond by bundling screens, trolleys, and cloud storage, shrinking the operational footprint in crowded ICUs.

Duodenoscopes remain a smaller slice of revenue but are projected to post a >9% CAGR to 2031 as elevator-contamination worries push ERCP suites to adopt premium-priced single-use scopes. Manufacturers now ship disposable elevators that satisfy FDA guidelines, and procurement teams see cost offsets from canceled maintenance contracts. Pilot projects in tertiary centers demonstrate scheduling gains because reprocessing backlogs disappear, encouraging regional hubs to follow once accessory compatibility widens.

Gastroenterology commanded 39.85% of the disposable endoscopes market size in 2025, driven by cross-contamination fears in ERCP and rising single-use adoption for outpatient colonoscopies. GI suites report fewer reprocessing delays, enabling denser scheduling that attracts patients in high-deductible insurance markets. The resulting operational efficiencies, paired with the availability of therapeutic channel expansion roadmaps, keep suppliers focused on developing GI-specific innovations.

Pulmonology shows the fastest growth because sustained bronchoscopy volumes for pneumonia diagnostics and lung-cancer staging fit well with disposable scope attributes. Clinicians cite reduced downtime and lower contamination risk during transbronchial needle aspiration as decisive factors. Hospitals integrate single-use bronchoscopy into quality-improvement metrics, boosting same-day biopsy rates and driving complementary demand for disposable retrieval baskets that match narrow channels.

Complete Report Scope:

• By Product
  • Gastroscopes
  • Bronchoscopes
  • Duodenoscopes
  • Laryngoscopes
  • Colonoscopes
  • Ureteroscopes
  • Other Endoscopes
• By Application Type
  • Gastroenterology
  • Pulmonology
  • Urology
  • ENT
  • Other Application Types
• By Procedure Type
  • Diagnostic
  • Therapeutic
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle-East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led the disposable endoscopes market with a 44.92% share in 2025. U.S. integrated delivery networks consolidate purchasing and negotiate volume rebates, while Joint Commission and CMS regulations elevate infection prevention to board-level priorities. Many hospitals defer washer-disinfector replacement once annual service costs exceed lease thresholds, channeling funds into single-use conversion programs. Canada follows a similar clinical rationale but relies on provincial technology grants that lengthen procurement cycles. The FDA’s 510(k) clearance pathway for single-use ureteroscopes like Olympus RenaFlex in 2024 gives clinical teams regulatory confidence.

Asia Pacific posts the highest regional CAGR at 8.61%. China’s provincial tenders include disposable scopes to meet infection-control targets under National Health Commission directives, favoring local manufacturers who avoid import duties. Private hospital chains in India advertise zero reprocessing backlogs as a differentiation lever, and cloud-connected processors streamline tele-mentoring for complex GI cases. Japan applies a selective approach, balancing its domestic reusable manufacturing dominance with the clinical benefits of disposables. South Korean firms such as Hunan Vathin trigger price competition that expands unit volumes despite margin compression, while Australia mandates carbon-accounting disclosures that recognize the lifecycle burden of chemical disinfectants. Europe shows fragmented adoption patterns. Nordic countries top per-capita usage, leveraging “Green OR” directives that prioritize carbon lifecycle metrics; scope recycling logistics now influence tender scores. Germany and France substitute disposables mainly for high-risk ERCP and ICU bronchoscopy, extending reusable fleets elsewhere to protect capital budgets. The UK’s NHS labels single-use scopes a tool for hitting zero-infection targets, yet broader adoption awaits budgetary alignment. Southern and Eastern Europe implement hybrid fleets: disposables for therapeutic ERCP, reusables for mass colonoscopy screenings. EU Medical Device Regulation costs strain small suppliers, potentially narrowing brand diversity and prompting hospital groups to lock multi-year deals with incumbent global vendors.

List of Companies Covered in this Report:

• Ambu
• Boston Scientific
• Olympus Corp.
• Fujifilm Holdings Corp.
• Pentax Medical (HOYA)
• Baxter
• Verathon
• Karl Storz
• STERIS
• Flexible Medical Systems Ltd.
• 3NT Medical Ltd.
• Coloplast
• ScoutCam Inc.
• OTU Medical Inc.
• Innovex Medical Co.
• Micro-tech
• Prunus Medical Co.
• Hunan Vathin Medical Instrument Co.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support